167 related articles for article (PubMed ID: 30262561)
1. Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia.
Contejean A; Resche-Rigon M; Tamburini J; Alcantara M; Jardin F; Lengliné E; Adès L; Bouscary D; Marçais A; Lebon D; Chabrot C; Terriou L; Barraco F; Banos A; Bussot L; Cahn JY; Hirsch P; Maillard N; Simon L; Fornecker LM; Socié G; de Latour RP; de Fontbrune FS
Haematologica; 2019 Feb; 104(2):256-262. PubMed ID: 30262561
[TBL] [Abstract][Full Text] [Related]
2. Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.
Lengline E; Drenou B; Peterlin P; Tournilhac O; Abraham J; Berceanu A; Dupriez B; Guillerm G; Raffoux E; de Fontbrune FS; Ades L; Balsat M; Chaoui D; Coppo P; Corm S; Leblanc T; Maillard N; Terriou L; Socié G; de Latour RP
Haematologica; 2018 Feb; 103(2):212-220. PubMed ID: 29170252
[TBL] [Abstract][Full Text] [Related]
3. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.
Vaht K; Göransson M; Carlson K; Isaksson C; Lenhoff S; Sandstedt A; Uggla B; Winiarski J; Ljungman P; Brune M; Andersson PO
Haematologica; 2017 Oct; 102(10):1683-1690. PubMed ID: 28751565
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of aplastic anemia: a prospective multicenter study.
Montané E; Ibáñez L; Vidal X; Ballarín E; Puig R; García N; Laporte JR;
Haematologica; 2008 Apr; 93(4):518-23. PubMed ID: 18322256
[TBL] [Abstract][Full Text] [Related]
5. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G
Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
[TBL] [Abstract][Full Text] [Related]
7. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group.
Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H
N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225
[TBL] [Abstract][Full Text] [Related]
8. Porcine antilymphocyte globulin (p-ALG) plus cyclosporine A (CsA) treatment in acquired severe aplastic anemia: a retrospective multicenter analysis.
Wei J; Huang Z; Guo J; Zhang Y; Wang C; Zhu X; Zhang Y
Ann Hematol; 2015 Jun; 94(6):955-62. PubMed ID: 25666078
[TBL] [Abstract][Full Text] [Related]
9. Treatment of aplastic anaemia with lower-dose anti-thymocyte globulin produces similar response rates and survival as per standard dose anti-thymocyte globulin schedules.
Scott A; Morris K; Butler J; Mills AK; Kennedy GA
Intern Med J; 2016 Oct; 46(10):1198-1203. PubMed ID: 27404498
[TBL] [Abstract][Full Text] [Related]
10. Unrelated alternative donor transplantation for severe acquired aplastic anemia: a study from the French Society of Bone Marrow Transplantation and Cell Therapies and the EBMT Severe Aplastic Anemia Working Party.
Devillier R; Dalle JH; Kulasekararaj A; D'aveni M; Clément L; Chybicka A; Vigouroux S; Chevallier P; Koh M; Bertrand Y; Michallet M; Zecca M; Yakoub-Agha I; Cahn JY; Ljungman P; Bernard M; Loiseau P; Dubois V; Maury S; Socié G; Dufour C; Peffault de Latour R
Haematologica; 2016 Jul; 101(7):884-90. PubMed ID: 27056924
[TBL] [Abstract][Full Text] [Related]
11. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
Sharma R; Chandra J; Sharma S; Pemde H; Singh V
J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.
Tichelli A; Socié G; Henry-Amar M; Marsh J; Passweg J; Schrezenmeier H; McCann S; Hows J; Ljungman P; Marin P; Raghavachar A; Locasciulli A; Gratwohl A; Bacigalupo A
Ann Intern Med; 1999 Feb; 130(3):193-201. PubMed ID: 10049197
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, Clinico-Haematological Profile and Management of Aplastic Anaemia: AIIMS Experience.
Mahapatra M; Singh PK; Agarwal M; Prabhu M; Mishra P; Seth T; Tyagi S; Patil HP; Saxena R
J Assoc Physicians India; 2015 Mar; 63(3 Suppl):30-5. PubMed ID: 26529865
[TBL] [Abstract][Full Text] [Related]
15. Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
Chen M; Zhuang J; Zhou D; Xu Y; Zhao Y; Wang S; Zhang W; Duan M; Zhu T; Li J; Cai H; Cao X; Han B
Ann Hematol; 2017 Apr; 96(4):581-587. PubMed ID: 28084534
[TBL] [Abstract][Full Text] [Related]
16. Outcome of adult severe or very severe aplastic anemia treated with immunosuppressive therapy compared with bone marrow transplantation: multicenter trial.
Ahn MJ; Choi JH; Lee YY; Choi IY; Kim IS; Yoon SS; Park SY; Kim BK; Suh C; Son HJ; Jung CW; Lee JH; Sung JM; Im SA; Oh D; Jung SY; Yoon HJ; Cho KS; Lee JA; Yuh YJ; Kim SR; Ki M
Int J Hematol; 2003 Aug; 78(2):133-8. PubMed ID: 12953807
[TBL] [Abstract][Full Text] [Related]
17. Incidence and treatment outcome of aplastic anemia in Taiwan-real-world data from single-institute experience and a nationwide population-based database.
Li SS; Hsu YT; Chang C; Lee SC; Yen CC; Cheng CN; Chen JS; Lin SH; Chang KC; Chen TY
Ann Hematol; 2019 Jan; 98(1):29-39. PubMed ID: 30178191
[TBL] [Abstract][Full Text] [Related]
18. Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study.
Atta EH; Dias DS; Marra VL; de Azevedo AM
Ann Hematol; 2010 Sep; 89(9):851-9. PubMed ID: 20373101
[TBL] [Abstract][Full Text] [Related]
19. Management of childhood aplastic anemia following liver transplantation for nonviral hepatitis: A French survey.
Delehaye F; Habes D; Dourthe ME; Bertrand Y; Michel G; Gaudichon J; Debray D; Nelken B; Pasquet M; Blanche S; Leblanc T
Pediatr Blood Cancer; 2020 Apr; 67(4):e28177. PubMed ID: 31925926
[TBL] [Abstract][Full Text] [Related]
20. [Aplastic anemia--clinical characteristics and survival analysis].
Milosević R; Antonijević N; Janković G; Babić D; Colović M
Srp Arh Celok Lek; 1998; 126(7-8):234-8. PubMed ID: 9863388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
